Skip to content

Clinical investigation to evaluate the performance and safety of Ambu® aScope* 4 Cysto and aView* Urologia for flexible cystoscopy.

Clinical investigation to evaluate the performance and safety of Ambu® aScope* 4 Cysto and aView* Urologia for flexible cystoscopy. - Performance and safety aScope 4 Cysto

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54961
Enrollment
60
Registered
2020-03-12
Start date
2020-07-21
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abnormalities in urethra and bladder

Interventions

The subjects will undergo a cystoscopy procedure.

Sponsors

Ambu AS
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: i. Adults (males and females), *18 years of age or older, presenting for cystoscopy ii. Ambulatory with a need to undergo cystoscopy for diagnostic or therapeutic purposes iii. Willing to participate in a clinical trial

Exclusion criteria

Exclusion criteria: i. History of high-grade bladder cancer or carcinoma-in-situ of the bladder, undergoing cystoscopy for follow-up/surveillance purposes ii. History of prior bladder/urethral reconstructive surgery iii. Presence of symptomatic urinary tract infection (UTI) iv. Known unpassable urethral stricture v. Unable to read and/or understand the study requirements vi. Unable or unwilling to provide consent to participation in the study vii. Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
The aim of this study is to evaluate the performance and safety of Ambu® aScope* 4 Cysto and aView* Urologia for flexible cystoscopy. Primary endpoint: - Rate of completion of procedure with Ambu® aScope* 4 Cysto and aView* Urologia (Yes/No, Yes applies to 80% of procedures)

Secondary

MeasureTime frame
- Rate of overall performance during the procedure - Rate of pain level experienced by the subject when inserting the flexible cystoscope (measured on a visual analog scale - Overall procedure time from insertion of flexible cystoscope to removal The intended performances that will be investigated during this clinical investigation are: * Manoeuvrability o Insertion of the endoscope in the lower urinary tract o Navigation in the bladder o Use of endoscopic accessories in the working channel * Use of the working channel (eg. Irrigation and tools) * Visual examination of the urothelium * Visual confirmation of anatomical structures * Visual confirmation of abnormalities in urethra and bladder

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)